ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/07/16 | 1,950 | 1,950 | 1,902 | 1,902 | -35 | -1.8% | 30,400 |
2020/07/15 | 1,928 | 1,937 | 1,909 | 1,937 | +33 | +1.7% | 38,000 |
2020/07/14 | 1,928 | 1,934 | 1,903 | 1,904 | -27 | -1.4% | 27,400 |
2020/07/13 | 1,900 | 1,932 | 1,888 | 1,931 | +59 | +3.2% | 47,100 |
2020/07/10 | 1,886 | 1,906 | 1,872 | 1,872 | -23 | -1.2% | 51,100 |
2020/07/09 | 1,875 | 1,906 | 1,867 | 1,895 | +29 | +1.6% | 62,300 |
2020/07/08 | 1,911 | 1,922 | 1,866 | 1,866 | -66 | -3.4% | 109,600 |
2020/07/07 | 1,941 | 1,942 | 1,912 | 1,932 | -24 | -1.2% | 66,800 |
2020/07/06 | 1,968 | 1,971 | 1,940 | 1,956 | -9 | -0.5% | 61,000 |
2020/07/03 | 1,965 | 1,977 | 1,961 | 1,965 | ±0 | ±0% | 28,600 |
2020/07/02 | 1,954 | 1,981 | 1,951 | 1,965 | +23 | +1.2% | 61,900 |
2020/07/01 | 2,002 | 2,009 | 1,942 | 1,942 | -59 | -2.9% | 69,900 |
2020/06/30 | 2,026 | 2,030 | 2,001 | 2,001 | -9 | -0.4% | 37,000 |
2020/06/29 | 2,013 | 2,018 | 2,000 | 2,010 | -11 | -0.5% | 29,400 |
2020/06/26 | 2,038 | 2,038 | 2,016 | 2,021 | +4 | +0.2% | 47,200 |
2020/06/25 | 2,005 | 2,029 | 2,001 | 2,017 | +11 | +0.5% | 79,500 |
2020/06/24 | 2,010 | 2,014 | 1,997 | 2,006 | -15 | -0.7% | 120,100 |
2020/06/23 | 2,034 | 2,047 | 2,012 | 2,021 | -6 | -0.3% | 42,300 |
2020/06/22 | 2,045 | 2,049 | 2,020 | 2,027 | -19 | -0.9% | 20,800 |
2020/06/19 | 2,050 | 2,068 | 2,016 | 2,046 | +6 | +0.3% | 116,000 |
2020/06/18 | 2,037 | 2,049 | 2,025 | 2,040 | -16 | -0.8% | 64,900 |
2020/06/17 | 2,042 | 2,075 | 2,038 | 2,056 | +14 | +0.7% | 63,800 |
2020/06/16 | 2,012 | 2,056 | 2,012 | 2,042 | +49 | +2.5% | 103,400 |
2020/06/15 | 2,000 | 2,034 | 1,988 | 1,993 | -7 | -0.4% | 109,800 |
2020/06/12 | 1,970 | 2,013 | 1,945 | 2,000 | -5 | -0.2% | 135,600 |
2020/06/11 | 2,029 | 2,029 | 2,005 | 2,005 | -33 | -1.6% | 81,800 |
2020/06/10 | 2,028 | 2,042 | 2,018 | 2,038 | +18 | +0.9% | 45,500 |
2020/06/09 | 2,040 | 2,049 | 2,018 | 2,020 | -13 | -0.6% | 51,700 |
2020/06/08 | 2,056 | 2,056 | 2,012 | 2,033 | -32 | -1.5% | 129,600 |
2020/06/05 | 2,090 | 2,090 | 2,051 | 2,065 | -23 | -1.1% | 67,500 |
2020/06/04 | 2,113 | 2,113 | 2,081 | 2,088 | -25 | -1.2% | 66,900 |
2020/06/03 | 2,166 | 2,166 | 2,098 | 2,113 | -15 | -0.7% | 45,400 |
2020/06/02 | 2,138 | 2,143 | 2,108 | 2,128 | -18 | -0.8% | 62,700 |
2020/06/01 | 2,135 | 2,149 | 2,115 | 2,146 | +21 | +1% | 56,600 |
2020/05/29 | 2,146 | 2,177 | 2,112 | 2,125 | -7 | -0.3% | 124,800 |
2020/05/28 | 2,148 | 2,148 | 2,089 | 2,132 | +12 | +0.6% | 64,300 |
2020/05/27 | 2,110 | 2,126 | 2,102 | 2,120 | -4 | -0.2% | 58,100 |
2020/05/26 | 2,116 | 2,129 | 2,082 | 2,124 | +17 | +0.8% | 60,200 |
2020/05/25 | 2,067 | 2,116 | 2,066 | 2,107 | +45 | +2.2% | 87,900 |
2020/05/22 | 2,222 | 2,222 | 2,059 | 2,062 | -128 | -5.8% | 218,100 |
2020/05/21 | 2,198 | 2,221 | 2,172 | 2,190 | +12 | +0.6% | 103,800 |
2020/05/20 | 2,182 | 2,183 | 2,141 | 2,178 | +4 | +0.2% | 64,400 |
2020/05/19 | 2,200 | 2,205 | 2,127 | 2,174 | -14 | -0.6% | 73,800 |
2020/05/18 | 2,140 | 2,190 | 2,140 | 2,188 | +57 | +2.7% | 73,800 |
2020/05/15 | 2,130 | 2,137 | 2,090 | 2,131 | +49 | +2.4% | 66,700 |
2020/05/14 | 2,113 | 2,120 | 2,082 | 2,082 | -26 | -1.2% | 35,200 |
2020/05/13 | 2,044 | 2,112 | 2,044 | 2,108 | +35 | +1.7% | 50,200 |
2020/05/12 | 2,073 | 2,095 | 2,061 | 2,073 | +10 | +0.5% | 30,900 |
2020/05/11 | 2,082 | 2,084 | 2,053 | 2,063 | -7 | -0.3% | 37,300 |
2020/05/08 | 2,070 | 2,070 | 2,032 | 2,070 | +35 | +1.7% | 59,700 |
1251~
1300
件表示中 / 3770件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 204,600円 | +3.1% | -6.5% | 2.35% | 9.50倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ジーエヌアイ | 263,100円 | +21.7% | +999.9% | 0.00% | 12.12倍 | 4.15倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 313,500円 | +5.1% | -7.0% | 2.55% | 20.58倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 244,500円 | +4.1% | -3.1% | 2.37% | 21.24倍 | 1.85倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
杏林製薬 | 152,600円 | -2.4% | -52.3% | 3.74% | 18.26倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム